Showing 10 posts of 10 posts found.

“Pharma Bro” Martin Shkreli charged by FTC for price fixing Daraprim

January 28, 2020
Manufacturing and Production FTC, Martin Shkreli, New York Attorney General, Pharma Bro

Martin Shkreli, also known as the “Pharma Bro”, has been charged by the Federal Trade Commission for price fixing. The …


Bristol-Myers Squibb to sell off Celgene’s Otezla ahead of $74 billion merger

June 24, 2019
Manufacturing and Production Bristol-Myers Squibb, Celgene, FTC, otezla, pharma, psoriasis

Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators. BMS will divest one of …

Teva settles ‘pay-to-delay’ case with FTC

February 21, 2019
Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly

Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …


Trump signs trust-busting biosimilar bill into law

October 11, 2018
Business Services, Sales and Marketing FTC, Trump, biosimilars, generics, us politics

President Donald J Trump has signed off a law which requires drugmakers and pharma firms to reveal the details of …


AbbVie ordered to pay $448m over generic delays

July 2, 2018
Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma

A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …


FTC launches tool to help mobile health app developers determine applicable regulations

April 8, 2016
Medical Communications, Sales and Marketing FDA, FTC, apps, health, health apps, regulation

The US Federal Trade Commission has created a new web-based tool for developers of health-related mobile apps to help them …

FTC files complaint against Endo for blocking generics of its pain drugs

April 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing Endo International, FTC, legal, regulation

The US Federal Trade Commission (FTC) has filed a complaint against Endo International (Nasdaq: ENDP) alleging the company used illegal …

Teva settles generic ‘pay-to-delay’ case for $1.2 billion

May 29, 2015
Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil

Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …

FTC building

Federal Trade Commission sues AbbVie and Teva

September 9, 2014
Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission

Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …

Pay-for-delay deals up 60% in US

May 6, 2011
Sales and Marketing FTC, generics

Deals to delay generic drugs from coming onto the US market have more than doubled. The Federal Trade Commission’s staff …

Latest content